VAP-B-PTPIP51 tethers have been linked to Parkinson’s disease and to amyotrophic lateral sclerosis (ALS) as well as to frontotemporal dementia (FTD) (i.e., diseases characterized by loss of synaptic function as a key pathogenic feature). This evidence concerns the gene RMDN3 and amyotrophic lateral sclerosis.